Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Picard Medical, Inc. ( (PMI) ) is now available.
On December 3, 2025, Picard Medical, Inc. announced that its CEO, Patrick NJ Schnegelsberg, will present data on the Emperor Total Artificial Heart at the CSI Focus D-HF conference in Frankfurt, Germany, scheduled for December 5-6, 2025. This participation highlights Picard Medical’s ongoing commitment to advancing heart failure device therapies and reinforces its position as a leader in the artificial heart industry.
More about Picard Medical, Inc.
Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which is based in Tucson, Arizona. SynCardia is known for its SynCardia Total Artificial Heart, the only commercially available artificial heart technology approved by both the U.S. FDA and Health Canada. This implantable system is designed for patients with end-stage heart failure and has been widely used in over 2,100 implants across 27 countries.
Average Trading Volume: 2,062,480
Learn more about PMI stock on TipRanks’ Stock Analysis page.